- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Everest Medicines announces regulatory updates in Taiwan, South Korea for Nefecon | ||
| Fr | Junshi Biosciences seeks UK's marketing authorisation for toripalimab | ||
| Do | FDA grants priority review to Takeda's BLA for dengue vaccine candidate | ||
| Mi | InnoCare receives approval in Singapore for mantle cell lymphoma therapy | ||
| 22.11. | Graybug, CalciMedica sign agreement to create new biopharmaceutical company | ||
| 21.11. | KemPharm receives Orphan Drug Designation for idiopathic hypersomnia prodrug | ||
| 18.11. | Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology | ||
| 17.11. | Curevo Vaccine announces closing of $26m Series A1 round | ||
| 16.11. | CG Oncology raises $120m through Series E round | ||
| 15.11. | NICE recommends MSD's pembrolizumab to treat breast cancer | ||
| 14.11. | US FDA accepts Amneal's NDA for IPX203 to treat Parkinson's disease | ||
| 11.11. | Harbour BioMed, Moderna partner on immunotherapies development | ||
| 10.11. | UK's MHRA approves Beyfortus (nirsevimab) to prevent RSV in infants | ||
| 09.11. | Immunomic Therapeutics receives FTD for ITI-3000 programme to treat Merkel Cell Carcinoma | ||
| 08.11. | Navrogen signs agreement with US NCI for NAV-001 development | ||
| 07.11. | Amgen's olpasiran reduces cardiovascular disease risk factor in Phase II study | ||
| 04.11. | ReiThera receives AIFA approval to open new production facility in Italy | ||
| 03.11. | BeiGene receives EC marketing approval for MZL therapy | ||
| 02.11. | PharmaTher, CWRU enter into agreement for Rett Syndrome therapy development | ||
| 01.11. | EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine development | ||
| 31.10. | EMA accepts Almirall's MAA filing for atopic dermatitis therapy | ||
| 28.10. | Ariceum, AmbioPharm partner to produce and supply peptide conjugates | ||
| 27.10. | CSL and Translational Sciences sign license deal for thrombus dissolving drug | ||
| 26.10. | Normunity raises funds to develop immuno-oncology therapies | ||
| 25.10. | FDA grants priority review for Daiichi Sankyo's AML medicine |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
